Clinical audit of patients using DPP4 inhibitors in longstanding type 2 diabetes

Diabetes and Metabolic Syndrome: Clinical Research and Reviews

Volumn 9, Issue 4, 2015, Pages 277-279

  Kumar, K V S Hari ^a   Gupta, A K ^a  

^a Command Hospital ^*  (India)

Author keywords

Clinical audit; DPP4 inhibitors; Gliptins; Type 2 diabetes

Indexed keywords

BIOLOGICAL MARKER; DIPEPTIDYL PEPTIDASE IV INHIBITOR; GLUCOSE BLOOD LEVEL;

AGED; CLINICAL AUDIT; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; MALE; METABOLISM; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR;

AGED; BIOMARKERS; BLOOD GLUCOSE; CLINICAL AUDIT; DIABETES MELLITUS, TYPE 2; DIPEPTIDYL-PEPTIDASE IV INHIBITORS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84900884793     PISSN: 18714021     EISSN: 18780334     Source Type: Journal    
DOI: 10.1016/j.dsx.2014.04.031     Document Type: Article

References (16)

1. K. Kazafeos Incretin effect: GLP-1, GIP, DPP4 Diabetes Res Clin Pract 93 2011 S32 S36
2. S. Del Prato, and P. Marchetti Beta- and alpha-cell dysfunction in type 2 diabetes Horm Metab Res 36 2004 775 781
3. J. Meece Pancreatic islet dysfunction in type 2 diabetes: a rational target for incretin-based therapies Curr Med Res Opin 23 2007 933 944
4. F.K. Knop, T. Vilsbøll, P.V. Højberg, S. Larsen, S. Madsbad, A. Vølund, and et al. Reduced incretin effect in type 2 diabetes: cause or consequence of the diabetic state? Diabetes 56 2007 1951 1959
5. B. Richter, E. Bandeira-Echtler, K. Bergerhoff, and C.L. Lerch Dipeptidyl peptidase-4 (DPP-4) inhibitors for type 2 diabetes mellitus Cochrane Database Syst Rev 2 2008 CD006739
6. B.H. Chew, S. Shariff Ghazali, M. Ismail, J. Haniff, and M.A. Bhujang Age ≥ 60years was an independent risk factor for diabetes-related complications despite good control of cardiovascular risk factors in patients with type 2 diabetes mellitus Exp Gerontol 48 2013 485 491
7. M.A. Bethel, F.A. Sloan, D. Belsky, and M.N. Feinglos Longitudinal incidence and prevalence of adverse outcomes of diabetes mellitus in elderly patients Arch Intern Med 167 2007 921 927
8. A.M. Abbatecola, and G. Paolisso Diabetes care targets in older persons Diabetes Res Clin Pract 86 2009 S35 S40
9. J. Gerich DPP-4 inhibitors: what may be the clinical differentiators? Diabetes Res Clin Pract 90 2010 131 140
10. Y.M. Mu, A. Misra, J.M. Adam, S.P. Chan, F.C. Chow, E.C. Cunanan, and et al. Managing diabetes in Asia: overcoming obstacles and the role of DPP-IV inhibitors Diabetes Res Clin Pract 95 2012 179 188
11. S.F. Praet, R.A. Jonkers, G. Schep, C.D. Stehouwer, H. Kuipers, H.A. Keizer, and et al. Long-standing, insulin-treated type 2 diabetes patients with complications respond well to short-term resistance and interval exercise training Eur J Endocrinol 158 2008 163 172
12. L.R. Reynolds, E.C. Konz, R.C. Frederich, and J.W. Anderson Rosiglitazone amplifies the benefits of lifestyle intervention measures in long-standing type 2 diabetes mellitus Diabetes Obes Metab 4 2002 270 275
13. S.H. Ko, S.A. Park, J.H. Cho, K.M. Shin, S.H. Lee, K.H. Song, and et al. Influence of the duration of diabetes on the outcome of a diabetes self-management education program Diabetes Metab J 36 2012 222 229
14. Vibha, and A.R. Laskar Women's health: beyond reproductive years Indian J Public Health 55 2011 247 251
15. R.V. Cohen, J.C. Pinheiro, C.A. Schiavon, J.E. Salles, B.L. Wajchenberg, and D.E. Cummings Effects of gastric bypass surgery in patients with type 2 diabetes and only mild obesity Diabetes Care 35 2012 1420 1428
16. S.K. Kota, S. Ugale, N. Gupta, V. Naik, K.V. Kumar, and K.D. Modi Ileal interposition with sleeve gastrectomy for treatment of type 2 diabetes mellitus Indian J Endocrinol Metab 16 2012 589 598